ARC logo.png
Covid-19 Vaccine Market Is Witnessing A Higher Pace Due To The Rise In The Number Of Patients - Report By Acumen Research And Consulting
25 mars 2021 11h57 HE | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, recently added a forthcoming report titled “Covid-19 Vaccine Market – Global Industry Analysis, Market Size, Opportunities...
Medolife Rx Announces Positive Results in Clinical Safety Study on Its Polarized Drug Candidate for the Treatment of COVID-19
18 mars 2021 08h30 HE | Quanta, Inc.
BURBANK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
University of Minnesota Medical School launches clinical trial studying metformin treatment for COVID-19
15 mars 2021 09h54 HE | University of Minnesota Medical School
Minneapolis / St. Paul, March 15, 2021 (GLOBE NEWSWIRE) -- A new multi-site clinical trial led by the University of Minnesota Medical School is studying the effectiveness of metformin, a generic...
ARC logo.png
COVID-19 Treatment Market Is Anticipated To Grow With Moderate CAGR During The Forecast Period 2020 – 2027: Acumen Research And Consulting
02 févr. 2021 11h11 HE | Acumen Research and Consulting
LOS ANGELES, Feb. 02, 2021 (GLOBE NEWSWIRE) -- According to Acumen Research and Consulting, the Global Covid-19 Treatment Market is anticipated to grow with moderate CAGR during the forecast period...
RelayMedicalLogo (3).jpg
Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results For COVID-19 Treatment Candidate Based On Its MyCell Technology™
14 janv. 2021 16h15 HE | Relay Medical Corp.
Glow LifeTech has the exclusive rights for MyCell Technology™ in the United States, Canada and Mexico for one of the primary ingredients used in ArtemiC™, a COVID-19 Treatment Candidate with...
Beroni Logo @ Dec 2019.png
Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020
09 nov. 2020 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise...
Beroni Logo @ Dec 2019.png
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19
19 oct. 2020 08h53 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise,...
Logo - RBT.jpg
Renibus Therapeutics’ COVID-19 Treatment, RBT-9, Shows Antiviral Activity Against SARS-CoV-2 In Vitro
07 oct. 2020 09h00 HE | Rénibus Therapeutics Inc.
DALLAS, Texas, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that its investigational treatment for COVID-19, RBT-9, has...
logo.png
Broward Health Medical Center Becomes First Clinical Site in U.S. for Phase II Trial for LSALT Peptide
28 juil. 2020 08h13 HE | Arch Biopartners
TORONTO, July 28, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating...
Logo - RBT.jpg
Renibus Therapeutics Receives FDA Fast Track Designation for RBT-9 Treatment in COVID-19
23 juin 2020 09h00 HE | Rénibus Therapeutics Inc.
DALLAS, Texas, June 23, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that it has been granted Fast Track designation by the FDA for...